Skip to content

A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese

A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01289288
Acronym
CRC
Enrollment
480
Registered
2011-02-03
Start date
2007-07-31
Completion date
2012-07-31
Last updated
2013-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

colorectal cancer screening, Chinese Americans, patients nonadherent with CRC Screening

Brief summary

The objective of this study is to test whether a culturally-tailored in-office based intervention have impact on increasing Chinese physician's recommendation of colorectal cancer (CRC) screening to their nonadherent Chinese patients. Special aims are to: 1. Evaluate the efficacy of a culturally-tailored physician intervention on increasing non-adherent Chinese American's patients' CRC screening rate. 2. Identify factors that mediate or moderate the intervention effects. For example, patients who hold an eastern cultural view or are less acculturated will be more likely to benefit from the intervention than patients who hold a western view or who are more acculturated.

Detailed description

This study is a randomized controlled trial aiming to test the effect of the culturally-tailored in-office based intervention on physicians. A total of 24 Chinese physicians in the Washington DC and Philadelphia areas and a total of 24 eligible Chinese patients from each physician will be recruited for this study. Physicians and their patients are randomized into two groups: A and B. Physician in the intervention group (A) will receive mailed printed materials including a CRC physician guide, patient brochure, flip chart and a poster and two sessions of in-office training aimed to reinforce learning of the topic covered by the mailed materials and provide physicians with hands-on experience in using communication skills with standardized patients. Physicians in the control group (B) will receive nothing until the end of the study. Patients will be followed 12-month later after their completion of the baseline survey and their self-reported CRC screening status will be verified by chart audit.

Interventions

BEHAVIORALMailed printed materials and in-office training

1. Mailed printed materials including CRC physician guide, patient brochure, flip chart and a poster 2. Two sessions of in-office training with two standardized patients

Sponsors

Temple University
CollaboratorOTHER
National Cancer Institute (NCI)
CollaboratorNIH
Georgetown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

For Physicians 1. are Chinese American, 2. practice primary care, 3. have a least 75 Chinese patients aged 50 and older in their practice, 4. can communicate with patients in Chinese (Mandarin, Cantonese, etc.) For Patients 1. visiting the participating physician at least once in the past 2 years, 2. are Chinese Americans, 3. are 50 years and older, 4. never had any CRC screening or are overdue for screening.

Exclusion criteria

For Patients: 1. have a colorectal polyp, CRC cancer, or a family history of CRC (first degree relative), and 2. had updated CRC screening (FOBT within one year, colonoscopy within 10 years, sigmoidoscopy within 5 years and double-contrast barium enema within 5 years).

Design outcomes

Primary

MeasureTime frameDescription
Receipt of CRC screening12 monthsNonadherent Chinese American patient's CRC screening rates.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026